Clinical Trial Update: Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of RBD1016 in participants with chronic hepatitis D is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• RBD1016 (RBD1016)

Snippet

Sponsor: Ribocure Pharmaceuticals AB | Conditions: Chronic Hepatitis D | Phase 2 | Status: ACTIVE_NOT_RECRUITING